Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (NovoMix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMELLI M)
Titel:
Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (NovoMix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMELLI M)
Auteur:
Aravind, S. R. Singh, Kiran P. Aquitania, Grace Mogylnytska, Liliia Zalevskaya, Alsu G. Matyjaszek-Matuszek, Beata Wernicke-Panten, Karin Nguyên-Pascal, My-Liên Pierre, Suzanne Rotthaeuser, Baerbel Kramer, Daniel Mukherjee, Bhaswati